On January 25, 2024, Eric Rowinsky, M.D., a director currently serving on the board of directors of Fortress Biotech, Inc. (the ?Company?), informed the Company that he does not intend to stand for re-election at the Company?s 2024 annual meeting of stockholders (the ?2024 Annual Meeting?) due to other professional commitments. Accordingly, Dr. Rowinsky?s service on the Company?s Board of Directors (the ?Board?) will end as of the date of the Company?s 2024 Annual Meeting. Dr. Rowinsky has not provided this notification as a result of any disagreement with the Company on any matter, including relating to the Company?s operations, policies or practices, and indeed the Company intends to continue engaging Dr. Rowinsky as a consultant following the date of his Board departure.